Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply - CNBC
- Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply CNBC
- A Popular Weight Loss Drug Is Getting a Price Cut The New York Times
- Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Investors | Eli Lilly and Company